Physician

Shahnoor Ali Khan, MD

According to 2025 Medicare claims, Shahnoor Khan, MD (NPI: 1346342458) practices psychiatry in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Berkeley, WV. This provider's primary affiliated billing organization is EASTERN PANHANDLE PSYCHIATRY, INC (NPI: 1407930225; TIN: 201855816) and primary practice location at 25403-1134. Khan is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 1,448 HCPCS/CPT codes, and received $121,007 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,742 prescription claims across 174 beneficiaries totaling $203,606 in drug costs, led by Invega Sustenna (Paliperidone Palmitate). Open Payments data shows 88 records totaling $25,502. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $414,497 and ending at $203,606. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	287	2,279	$140,665
2016	250	2,315	$135,413
2017	274	3,065	$174,710
2018	259	2,879	$171,443
2019	251	2,259	$142,918
2020	229	2,395	$176,381
2021	182	1,638	$150,683
2022	199	1,611	$139,231
2023	200	2,063	$182,233
2024	125	1,448	$121,007

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	209	3,761	$414,497
2016	212	3,898	$346,001
2017	207	3,123	$297,761
2018	181	2,519	$263,849
2019	203	2,402	$359,783
2020	206	2,523	$383,879
2021	193	2,193	$306,557
2022	244	2,782	$474,710
2023	244	2,261	$343,346
2024	174	1,742	$203,606

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	22	22	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	111	652	$80
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	15	48	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	53	140	$62
90833	Psychotherapy with evaluation and management visit, 30 minutes	53	108	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Invega Sustenna	Paliperidone Palmitate	12	360	$39,661
Trintellix	Vortioxetine Hydrobromide	13	810	$12,138
Lurasidone Hcl	Lurasidone Hcl	25	1,530	$11,695
Ozempic	Semaglutide	11	314	$10,124
Aripiprazole	Aripiprazole	58	3,840	$5,468

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$25,502	Supernus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shahnoor Ali Khan, MD?

Tedicare shows public-source Medicare data for Shahnoor Ali Khan, MD (NPI 1346342458), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shahnoor Ali Khan, MD have ACO affiliation data?

Shahnoor Ali Khan, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Shahnoor Ali Khan, MD?

Shahnoor Ali Khan, MD is linked to EASTERN PANHANDLE PSYCHIATRY, INC (billing NPI 1407930225) in the available physician profile data.

Does Shahnoor Ali Khan, MD have Open Payments data?

Shahnoor Ali Khan, MD has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.